• Equine
  • Wormers
  • Equest Pramox Horse Wormer (Moxidectin) Treats 700kg
Equest Pramox Horse Wormer (Moxidectin) Treats 700kg

Equest Pramox Horse Wormer (Moxidectin) Treats 700kg

In Stock
Brand Image
Click on stars to rate this product
Write a review
Quantity Discount Unit Price
1-9 - £24.95
10-29 6.00% £23.45
30+ 9.00% £22.70
Equest Pramox is the longest lasting and most effective horse wormer and one syringe now Treats up to 700kg.
Read more about this product »
Add to Basket
  • Equest Pramox Horse Wormer 700kg
  • Presentation
  • Dosage & Administration
  • Contra-indications & Warnings
  • Reviews


Equest Pramox is the longest lasting and most effective horse wormer and one syringe now Treats up to 700kg.  Ideal to use in Spring and Autumn.

Equest Pramox
gives Tapeworm 6 months protection
Redworm 13 weeks protection
Equest Pramox
is licensed for the use in foals from 6 1/2 months of age

The Veterinary medicinal product has been shown to be safe for use in breeding, pregnant and lactating mares.  The administration of the product does not adversely affect the fertility of the mares.

This Equest Pramox wormer syringe will treat 700kg

Do not use Equest Pramox for sick or neglected horses.

Equest Pramox
contains Moxidectin and Praziquentel. Equest Pramox is a combination of two drugs in one horse wormer treats roundworm, tapeworm, bots, and encysted redworm larvae stages in horses.

Use Equest Pramox wormer alternately with Equest every quarter for a years complete worming programme. Thats just four single doses a year, one for each season!

contains moxidectin, the unique active ingredient of EQUEST, and praziquantel, the drug of choice for the control of tapeworm.

EQUEST PRAMOX is the only combination wormer licensed to control small redworms, including the inhibited and developing encysted small redworm larval stages, as well as other roundworm species, bots and all three species of tapeworm.

EQUEST PRAMOX has the longest dosing interval of any combination wormer: 13-weeks. The active ingredient moxidectin prevents the reappearance of roundworm eggs in the horse’s dung for at least 90 days, which is longer than any other active ingredient, this gives EQUEST PRAMOX its 13-week dosing interval.

EQUEST PRAMOX is easy to administer in a palatable gel formula. EQUEST PRAMOX melts in your horse’s mouth to reduce the risk of being spat out. Presented in easy to use dial-a-dose syringes with 25kg graduations; this allows accurate dosing according to your horse’s weight.

EQUEST PRAMOX has no confirmed resistance in horses in the UK or Ireland. EQUEST PRAMOX is licensed to control the increasingly prevalent benzimidazole (fenbendazole and mebendazole) resistant strains of small redworm. Making it a suitable treatment for new horses arriving at a yard.

is safe to use in horses and ponies, including stallions and mares, and is licensed for use in foals from 6 ½ months.

Pharmaceutical precautions

Do not store above 25°C. Use within 6 months after opening. Do not use after the expiry date stated on the carton after "EXP". Packaging Quantities HDPE syringe containing 14.4g of gel with graduated polypropylene plunger and LDPE cap Further information Parasite resistance to a particular class of anthelmintic may develop following frequent, repeated use of an anthelmintic of that class. The veterinary surgeon should give advice regarding appropriate dosing programmes and stock management to achieve adequate parasite control for both tapeworm and roundworm infestations. In the case of cestode treatment the dose of praziquantel in the product has been selected at the top end of the dosing range. Flaccid lower lip, ataxia and swelling of the muzzle could be observed on rare occasions in young animals. These adverse effects are transient and disappear spontaneously. In adults transient adverse reactions may occur at 3 times the recommended dose. The symptoms are depression, inappetence, ataxia, flaccid lower lip in the 8 to 24 hours following treatment. Symptomatic treatment is not generally necessary and recovery is generally complete within 24 to 72 hours. There is no specific antidote. In case of very high worm burdens, destruction of the parasites may cause a mild transient colic and loose faeces in the treated horse. EQUEST PRAMOX Oral Gel is specially formulated to be easily expelled by the syringe plunger. Once in the horse’s mouth, EQUEST PRAMOX Oral Gel liquefies. This facilitates dosing and reduces the risk of rejection.


These products, as well as being available from vets and pharmacists, can be supplied by a suitably qualified person (SQP) from a pharmacy registered with the General Pharmaceutical Council (GPhC) and from premises approved by the Veterinary Medicines Directorate (VMD). Our SQP Mrs Diane Harris, number QE7160, is available for advice regarding worming schedules and procedures if required.

Within the current legislation it is our duty to determine the purchaser is a legitimate buyer and owner of an animal requiring treatment. Upon completion of purchasing these goods you will be asked some questions regarding the animal for compliance with the Veterinary Medicines Regulations, please be aware that we may contact you to confirm any details if necessary.

If you are buying a medicine for a horse that is NOT signed out of the food chain (section IX of its passport) you should ensure that the product is suitable

Always read the instructions before use.

Safety precautions may be necessary during administration, please consult the packaging and/or product literature.

This is for food producing animals.

To ensure that you read the most up to date information about this product, please check the VMD’s Product Information Database

Equest Pramox
is a pale yellow to orange/pink gel containing 19.5mg/g moxidectin and 121.7mg/g praziquantel as active ingredients and 220.0mg/g benzyl alcohol and 0.80mg/g butyl hydroxytoluene as preservatives/antioxidants.

Uses Moxidectin is a second-generation macrocyclic lactone of the milbemycin family.

Praziquantel is a parasiticide widely used in many species for the specific control of tapeworm.

For the single dose treatment of mixed cestode and nematode or arthropod infections in horses and ponies; caused by moxidectin and praziquantel sensitive strains of: Large redworm (large strongyles): - Strongylus vulgaris (adults) - Strongylus edentatus (adults) - Triodontophorus brevicauda (adults) - Triodontophorus serratus (adults) - Triodontophorus tenuicollis (adults) Small redworm (small strongyles/cyathostomin) (adults and intraluminal larval stages): - Cyathostomum spp. - Cylicocyclus spp. - Cylicostephanus spp. - Cylicodontophorus spp. - Gyalocephalus spp. Ascarids: - Parascaris equorum (adults) Other roundworm species: - Oxyuris equi (adults) - Habronema muscae (adults) - Strongyloides westeri (adults) - Trichostrongylus axei (adults) Bots: - Gasterophilus intestinalis (L2, L3) - Gasterophilus nasalis (L2, L3) Tapeworm: - Anoplocephala perfoliata - Anoplocephala magna - Anoplocephaloides mamillana The egg reappearance period of small redworm is 90 days.

Dosage and administration

Equest Pramox is for oral administration
. One 14.4g syringe contains sufficient gel to treat a 700kg horse at the recommended dose rate (0.4mg moxidectin per kg bodyweight and 2.5mg praziquantel per kg bodyweight). Each graduation on the calibrated syringe delivers sufficient gel to treat 25kg bodyweight. Use of a scale or weight tape is recommended to ensure accurate dosing. To avoid overdosing, care should be taken to accurately dose foals, especially low bodyweight foals or pony foals. Dosing guideline The recommended dosing interval for the control of small redworm is 13 weeks. For optimum control of bots, the product should be administered in the autumn, after the end of the fly season and before spring as the larvae may start to pupate and therefore are less sensitive to treatment.

Veterinary advice should be given on appropriate dosing programmes and stock management to achieve optimum parasite control.

Contra-indications, warnings, etc

Horses must not be slaughtered for human consumption within 64 days of treatment.

Do not administer to young foals less than 6.5 months of age.

Do not use in cases of hypersensitivity to the active substance or to any of the excipients.

EQUEST PRAMOX Oral Gel is formulated specifically for use in horses only. Dogs or cats may be adversely affected by the concentration of moxidectin in this product if they are allowed to ingest spilled gel or have access to used syringes.

Do not use the same syringe to treat more than one animal unless horses are running together or in direct contact with each other on the same premises. 

Equest Pramox may cause eye irritation, skin irritation and skin sensitisation. Avoid direct contact with skin and eyes. The use of protective gloves is recommended. Wash hands or any exposed area after use. Do not smoke, drink or eat while handling the product. In the event of eye contact flush the eye with copious amounts of clean water and seek medical advice. In case of accidental ingestion, seek medical help and show the doctor the package insert.

For animal treatment only. Keep out of the reach and sight of children.

Read entire package insert before use. Environmental safety In order to limit the impact of moxidectin on dung fauna, and due to insufficient data regarding environmental risk of praziquantel, horses should not be turned out onto pasture within 3 days of treatment.

EQUEST PRAMOX Oral Gel is toxic to fish and aquatic organisms. Do not contaminate ponds, waterways or ditches with product or used syringes. Dispose of any unused product and empty syringes in accordance with guidance from your local waste regulation authority.

  Average rating (0 reviews) Write a Review